Press · Newsroom
Official releases from the research desk.
590 announcements — new study launches, forecast revisions and executive commentary — issued directly by the Exactitude analyst team. Media use permitted with attribution.
January
41–60 of 162
-
19 JAN 2026
mRNA-Based Vaccines and Therapeutics Market Overview and Growth Outlook
mRNA-based vaccines and therapeutics represent a transformative approach in modern medicine, using messenger RNA to instruct cells to produce specific proteins that trigger immune responses or treat …
-
19 JAN 2026
Dyspareunia Therapeutics Market Current Treatments and Pipeline Analysis
Dyspareunia is a medical condition characterized by persistent or recurrent pain during sexual intercourse, affecting a significant proportion of women and, less commonly, men.
-
19 JAN 2026
Congenital Ichthyosis Therapeutics Market Current Treatments and Pipeline Analysis
Congenital Ichthyosis refers to a group of rare, inherited skin disorders characterized by abnormal skin scaling, dryness, thickening, and impaired skin barrier function present from birth.
-
19 JAN 2026
Cannabis Use Disorder (CUD) Market Regulatory, Policy, and Access Landscape
Cannabis Use Disorder (CUD) is a clinical condition characterized by problematic cannabis use that leads to significant impairment or distress. With the global rise in cannabis legalization, medical …
-
19 JAN 2026
Urea Cycle Disorders (UCD) Drugs Market Current Therapies and Pipeline Outlook
The UCD market was valued at approximately USD 1.3–2.1 billion in 2024, depending on the scope of analysis and inclusion of supportive care services. The market is projected to expand significantly a…
-
19 JAN 2026
Endometriosis Market Increasing Disease Awareness and Advancements in Hormonal Therapies Fueling Market Growth
The global Endometriosis Market is witnessing steady expansion, driven by rising disease awareness, improved diagnostic capabilities, and continuous advancements in hormonal and non-hormonal treatmen…
-
19 JAN 2026
Cervical Dysplasia Market Expanding HPV Screening Programs and Preventive Therapies Driving Early Intervention Demand
Cervical dysplasia refers to the presence of abnormal precancerous cells on the cervix, most commonly caused by persistent infection with high-risk types of human papillomavirus (HPV).
-
19 JAN 2026
Premature Labor (Tocolysis) Market Rising Preterm Birth Rates Driving Demand for Advanced Maternal–Fetal Care Therapies
Premature labor, also referred to as preterm labor, occurs when regular uterine contractions lead to cervical changes before 37 weeks of gestation.
-
19 JAN 2026
Pelvic Inflammatory Disease Market Growing STI Prevalence Driving Demand for Early Diagnosis and Effective Antibiotic Therapies
Pelvic Inflammatory Disease (PID) is a serious infection of the female reproductive organs, most commonly caused by sexually transmitted infections such as Chlamydia trachomatis and Neisseria gonorrh…
-
19 JAN 2026
Radiotherapy-Induced Oral Mucositis Market Rising Demand for Supportive Oncology Care Amid Growing Cancer Burden
Radiotherapy-induced oral mucositis is a common and debilitating complication experienced by patients undergoing radiotherapy, particularly for head and neck cancers.
-
16 JAN 2026
Radiotherapy-Induced Oral Mucositis Market Industry Trends, Competitive Landscape, and Forecast
The global radiotherapy-induced oral mucositis treatment market was valued at approximately USD 1.7–1.9 billion in 2024 and is expected to grow steadily at a CAGR of around 4.5%–5.5% over the forecas…
-
16 JAN 2026
Oral Mucositis Market Treatment Market Industry Trends, Competitive Landscape, and Forecast
The global oral mucositis market was valued at approximately USD 2.8–3.2 billion in 2024 and is expected to grow at a CAGR of around 4.5%–5.8% during the forecast period.
-
16 JAN 2026
Bacterial Vaginosis Market Growth Driven by Aging Female Population and Innovation in Women’s Health
The global bacterial vaginosis (BV) market was valued at approximately USD 1.2–1.4 billion in 2024 and is expected to grow at a CAGR of around 5.5%–6.5% during the forecast period.
-
16 JAN 2026
Zygomatic and Pterygoid Implant Market Industry Trends, Competitive Landscape, and Forecast
The global zygomatic and pterygoid implant market was valued at approximately USD 380–450 million in 2024 and is projected to grow at a CAGR of around 6.5%–8.0% during the forecast period.
-
16 JAN 2026
Menopause Market Analysis: Emerging Therapies, Market Dynamics, and Future Growth
The global menopause market was valued at approximately USD 16.5–18.0 billion in 2024 and is expected to grow at a CAGR of around 6.0%–7.2% during the forecast period.
-
16 JAN 2026
Postoperative Acute Pain Market Size, Forecast, Outlook, Trends - 2034
Postoperative acute pain is pain experienced immediately after surgical procedures and is a critical aspect of perioperative care. Effective management of postoperative pain improves patient recovery…
-
16 JAN 2026
Non-Postoperative Acute Pain Market Unmet Needs Driving Innovation
Non-postoperative acute pain refers to sudden, short-term pain not associated with surgical procedures. It commonly arises from conditions such as musculoskeletal injuries, trauma, fractures, acute b…
-
16 JAN 2026
Inflammation and Pain Post-Cataract Surgery Market Analysis Report - 2034
Inflammation and pain following cataract surgery are common postoperative complications that can affect visual recovery, patient comfort, and overall surgical outcomes.
-
16 JAN 2026
GM2 Gangliosidosis Market Unmet Medical Needs and Commercial Opportunities
GM2 Gangliosidosis is a rare, inherited lysosomal storage disorder caused by the deficiency of enzymes responsible for breaking down GM2 gangliosides, leading to toxic accumulation in nerve cells.
-
16 JAN 2026
Antibody-Mediated Rejection Market Landscape, Current Therapies and Future Outlook
Antibody-Mediated Rejection (AMR) is a critical immune-driven complication observed after solid organ transplantation, where recipient antibodies attack donor antigens, leading to graft injury and po…
Media enquiries
Working on a story? The analyst desk is available for comment.
Data extracts, executive quotes and pre-release embargo access for accredited business media. Response within one business day.